Still Perfecting Radioiodine in Thyroid Cancer, After All These Years
- PMID: 30462299
- DOI: 10.1210/jc.2018-02437
Still Perfecting Radioiodine in Thyroid Cancer, After All These Years
Comment on
-
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.J Clin Endocrinol Metab. 2019 May 1;104(5):1417-1428. doi: 10.1210/jc.2018-01478. J Clin Endocrinol Metab. 2019. PMID: 30256977 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
